ZJU Index as a Predictive Tool for Diabetes Incidence: Insights from a Population-Based Cohort Study

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1(Suppl 1):S67–S74. doi:10.2337/dc13-S067
   PubMed Web of Science ®Google Scholar
• Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790. doi:10.1038/s41598-020-71908-9
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabet Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Nanditha A, Ma RCW, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the Global Epidemic. Diabetes Care. 2016;39(3):472–485. doi:10.2337/dc15-1536
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69–82. doi:10.1016/S0140-6736(13)60591-7
   PubMed Web of Science ®Google Scholar
• Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17). doi:10.3390/ijms21176275
   Web of Science ®Google Scholar
• Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015;4(2):101–108. doi:10.3978/j.issn.2304-3881.2015.01.03
   PubMed Web of Science ®Google Scholar
• Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. doi:10.1038/s41575-021-00448-y
   PubMed Web of Science ®Google Scholar
• Kasturiratne A, Weerasinghe S, Dassanayake AS, et al. Influence of nonalcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol. 2013;28(1):142–147. doi:10.1111/j.1440-1746.2012.07264.x
   PubMed Web of Science ®Google Scholar
• Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Nonalcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962–969. doi:10.1136/gutjnl-2020-322572
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Tang Y, et al. Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: evidence from the Dongfeng-Tongji cohort study. PLoS One. 2017;12(3):e0174291. doi:10.1371/journal.pone.0174291
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004
   PubMed Web of Science ®Google Scholar
• Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of nonalcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038–1048. doi:10.1016/j.metabol.2015.12.012
   PubMed Web of Science ®Google Scholar
• Wang J, Ma L, Chen S, et al. Risk for the development of nonalcoholic fatty liver disease: a prospective study. J Gastroenterol Hepatol. 2018;33(8):1518–1523. doi:10.1111/jgh.14105
   PubMed Web of Science ®Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(33):567.
   Google Scholar
• Higashiura Y, Furuhashi M, Tanaka M, et al. High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. Sci Rep. 2021;11(1):12830. doi:10.1038/s41598-021-92292-y
   PubMedGoogle Scholar
• Zhu Y, Hu H, Wu Y, et al. The association between fatty liver index and onset of diabetes: secondary analysis of a population-based cohort study. BMC Public Health. 2023;23(1):679. doi:10.1186/s12889-023-15442-z
   PubMed Web of Science ®Google Scholar
• Seo I-H, Lee HS, Lee Y-J. Fatty liver index as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years. Cardiovasc Diabetol. 2022;21(1):209. doi:10.1186/s12933-022-01642-1
   PubMed Web of Science ®Google Scholar
• Cho E-J, Jung G-C, Kwak M-S, et al. Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population. Diagnostics. 2021;11(12):46.
   Web of Science ®Google Scholar
• Wang J, Xu C, Xun Y, et al. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5(16494). doi:10.1038/srep16494
   Google Scholar
• Hashimoto Y, Hamaguchi M, Kojima T, et al. Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study. J Gastroenterol Hepatol. 2015;30(3):546–552. doi:10.1111/jgh.12786
   PubMed Web of Science ®Google Scholar
• Wedekind LE, Mahajan A, Hsueh W-C, et al. The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population. Diabetologia. 2023;66(5):847–860. doi:10.1007/s00125-023-05870-2
   PubMed Web of Science ®Google Scholar
• Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–731.
   PubMed Web of Science ®Google Scholar
• Lee YH, Cho Y, Lee BW, et al. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: epidemiology and Diagnosis. Diabetes Metab J. 2019;43(1):31–45. doi:10.4093/dmj.2019.0011
   PubMed Web of Science ®Google Scholar
• Dharmalingam M, Yamasandhi PG. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Indian J Endocrinol Metab. 2018;22(3):421–428. doi:10.4103/ijem.IJEM_585_17
   PubMedGoogle Scholar
• Gutiérrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological Molecular Mechanisms of Obesity: a Link between MAFLD and NASH with Cardiovascular Diseases. Int J Mol Sci. 2021;22(21). doi:10.3390/ijms222111629
   PubMed Web of Science ®Google Scholar
• Lambrinou E, Hansen TB, Beulens JW. Lifestyle factors, self-management and patient empowerment in diabetes care. Eur J Prev Cardiol. 2019;26(2_suppl):55–63. doi:10.1177/2047487319885455
   PubMed Web of Science ®Google Scholar
• Durlach V, Vergès B, Al-Salameh A, et al. Smoking and diabetes interplay: a comprehensive review and joint statement. Diabetes Metab. 2022;48(6):101370. doi:10.1016/j.diabet.2022.101370
   PubMed Web of Science ®Google Scholar
• Sato KK, Hayashi T, Harita N, et al. Relationship between drinking patterns and the risk of type 2 diabetes: the Kansai Healthcare Study. J Epidemiol Community Health. 2012;66(6):507–511. doi:10.1136/jech.2010.109777
   PubMed Web of Science ®Google Scholar
• Li MJ, Ren J, Zhang WS, et al. Association of alcohol drinking with incident type 2 diabetes and prediabetes: the Guangzhou Biobank Cohort Study. Diabetes Metab Res Rev. 2022;38(6):e3548. doi:10.1002/dmrr.3548
   PubMed Web of Science ®Google Scholar
• C-P F, Ali H, Rachakonda VP, Oczypok EA, DeLany JP, Kershaw EE. The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women. PLoS One. 2019;14(11):e0224942. doi:10.1371/journal.pone.0224942
   PubMed Web of Science ®Google Scholar
• Li L, You W, Ren W. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population. Acta Diabetol. 2017;54(10):905–911. doi:10.1007/s00592-017-1024-8
   PubMed Web of Science ®Google Scholar
• Brambilla P, La Valle E, Falbo R, et al. Normal fasting plasma glucose and risk of type 2 diabetes. Diabetes Care. 2011;34(6):1372–1374. doi:10.2337/dc10-2263
   PubMed Web of Science ®Google Scholar